Articles
Study evaluates effect of Viusid on oxidative stress, cytokine parameters in patients with CHC
The pathogenesis of chronic hepatitis C (CHC) is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect.
Study Shows Possible Benefit of <[censored]> Extract for Hepatitis C Virus
Recent research, funded in part by NCCAM and published in the journal Gastroenterology, has shown that an extract of the milk thistle plant may help treat hepatitis C virus infection. Hepatitis C, a liver disease caused by a virus, is usually chronic (long-lasting), with symptoms ranging from mild (or even none) to severe.
The Chemo Concession Persists
A recent study provides evidence that some oncologists prescribe chemotherapy based on their financial reward rather than the medical needs of their patients. This is a continuation of the "Chemotherapy Concession," which came to public light a decade ago. It is a system, unique in the medical world, whereby oncologists can buy drugs at deep discount and then dispense them at the higher, Medicare rate in their offices. In effect, participating oncologists run a kind of pharmacy as a side business (although it is rarely identified as such to the patients).
Chronic lymphocytic leukemia breakthrough: <[censored]> halts cancer progression in majority of patients
(NaturalNews) According to the National Institutes of Health (NIH), chronic lymphocytic leukemia (CLL) is a form of cancer that causes the number of white blood cells called B lymphocytes, or B cells, to increase abnormally. Eventually, the cancerous cells can move through the blood to the liver, spleen, and other organs. When CLL spreads, it is usually treated with an arsenal of side effect-laden chemotherapies.
But new research has revealed a natural substance -- an extract of green tea -- may have the ability to put the brakes on CLL.
Groundbreaking Drug-Free Treatment for Hepatitis C
A potentially groundbreaking study has shown that a nutritional supplement was effective in treating patients with hepatitis C who do not respond to standard antiviral therapy. The research, published in the June 7, 2010 issue of the World Journal of Gastroenterology, was conducted by doctors at the National Institute of Gastroenterology in Havana, Cuba.
Rock legend Gregg Allman gets new liver...
Rock and roll legend, Gregg Allman, is recovering after successfully undergoing liver transplant surgery this week in Florida. The 62 year-old picker and crooner was said to be "groggy but awake" following the Wednesday morning surgery. Gregg Allman, who was diagnosed with
Hepatitis C in 2007, received his liver transplant operation at the Mayo Clinic in Jacksonville, Fla. He had been on a waitiing list for several years.
Human Genome Sciences expecting FDA to reject hepatitis C drug Zalbin
Rockville-based Human Genome Sciences said Monday that it doubts that federal regulators will approve its treatment for chronic hepatitis C after the drug received an unfavorable preliminary review from the Food and Drug Administration.